Xiaoting Ma Xiu Liu Kai Ou Manman Zhang Lizhen Gao Lin Yang
10.3389/fonc.2023.1151178
Front Oncol
2023 Apr 6;13:1151178.
egfr furmonertinib nimotuzumab pancreatic cancer targeted therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/37091175/
Case Reports
PMC10117981
37091175
Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report
2023